Document:

EX-10.8

 Exhibit 10.8 

Dated March / 1 / 2022 

TRANSITIONAL TRADEMARK LICENSE AGREEMENT 

by and between 
 ZIMMER BIOMET
HOLDINGS, INC. 
 and 

ZIMVIE INC. 

 TABLE OF CONTENTS 

 

							
			
	 1.
	 	 Definitions
	  	 	1	 
			
	 2.
	 	 License Grant
	  	 	3	 
			
	 3.
	 	 Restrictions
	  	 	5	 
			
	 4.
	 	 Ownership
	  	 	6	 
			
	 5.
	 	 Quality Control
	  	 	6	 
			
	 6.
	 	 Representations and Warranties; Covenants
	  	 	7	 
			
	 7.
	 	 Limitation of Liability
	  	 	8	 
			
	 8.
	 	 Confidentiality
	  	 	8	 
			
	 9.
	 	 Term and Termination; Remedies
	  	 	9	 
			
	 10.
	 	 Miscellaneous
	  	 	10	 
		
	 Schedule 1 Licensed Trademarks
	  	 	15	 
		
	 Schedule 2 Licensed Domain Names
	  	 	55	 
		
	 Schedule 3 Trademark Guidelines
	  	 	56	 

  

 TRANSITIONAL TRADEMARK LICENSE AGREEMENT 

This TRANSITIONAL TRADEMARK LICENSE AGREEMENT (together with all Schedules attached hereto, this “Agreement”), is made
effective as of March 1, 2022 (the “Effective Date”), by and between Zimmer Biomet Holdings, Inc., a Delaware corporation (“Parent”), and ZimVie Inc., a Delaware corporation (“SpinCo”). Each of
Parent and SpinCo may individually be referred to in this Agreement as a “Party” and collectively as the “Parties.” 

RECITALS 
 WHEREAS,
Parent and SpinCo have entered into that certain Separation and Distribution Agreement, dated as of March 1, 2022, by and between Parent and SpinCo (as it may be amended or supplemented, the “Separation and Distribution
Agreement” or “SDA”), for the contribution, assignment, transfer, conveyance and delivery to SpinCo (as defined in the Separation and Distribution Agreement) of certain assets owned by the Parent and Parent Group (as
defined in the Separation and Distribution Agreement); 
 WHEREAS, pursuant to the Separation and Distribution Agreement, the Parties
have agreed to deliver, or cause to be delivered, executed copies of this Agreement on or prior to the Effective Time; 
 WHEREAS,
Parent and Parent Group are the owners of the Licensed Trademarks; and 
 WHEREAS, SpinCo desires to receive a license to use the
Licensed Trademarks for a transitional basis, and Parent is willing to grant such license pursuant to the terms and conditions set forth in this Agreement. 

NOW, THEREFORE, in consideration of the mutual agreements, provisions and covenants contained in this Agreement and the Separation and
Distribution Agreement and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, hereby agree as follows: 

1. Definitions. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the
Separation and Distribution Agreement. For the purpose of this Agreement, the following terms shall have the following meanings: 

1.1 “Commercialize” means to sell, offer for sale, distribute, import, market, promote, or otherwise
commercialize. 
 1.2 “Corporate Name” means, with respect to SpinCo and each of the members of the SpinCo
Group, the corporate name, registered name or registered fictitious name of such entity as of the Effective Date. 
 1.3
“Corporate Name Term” has the meaning set forth in Section 2.2(a). 
 1.4
“Domain Names” means Internet domain names, including top level domain names and global top level domain names, URLs, social media identifiers, handles and tags. 

1.5 “Existing Inventory” has the meaning set forth in Section 2.5(b). 

1.6 “Field” means the field of (a) developing, designing, manufacturing, having manufactured, importing,
exporting, selling, offering for sale, marketing, distributing and otherwise commercializing: (i) either (A) dental reconstructive implants, dental prosthetic products, dental regenerative products, dental treatment design or planning software
or services, digital dentistry products or services, (B) implants or surgical instruments whose primary purpose is the placement 

 
of bone fixation or motion preservation devices in or attachment to the vertebral column (including pedicle screws, disc repair and/or replacement devices, and the placement of interbody fusion
or motion preservation devices for the treatment of degenerative conditions, deformities, disease, tumors or traumatic injury of the spine) or (C) non-invasive and implantable bone growth stimulation
products; and (ii) any and all associated instrumentation (including patient specific instrumentation), treatment or surgical planning, surgical navigation and surgical techniques and (b) seeking and maintaining all necessary approvals in
connection with any of the foregoing, provided, however, that the “Field” expressly excludes: the development, design, manufacture, having manufactured, importation, exportation, sale, offer for sale, marketing, distribution or other
commercialization of products, instruments or surgical techniques primarily related to the brain, brain stem, spinal cord, maxillofacial surgery, craniomaxillofacial reconstructive surgery, orthognathic surgery, and/or craniotomy procedures
(including, for clarity, brain biopsy procedures, brain ablation procedures, deep brain stimulation, nerve root stimulation, epidural needle placement, and/or dural procedures such as for the removal of spinal cord tumors). 

1.7 “Licensed Products” means those SpinCo Products Commercialized under the SpinCo Business that contain,
bear, display or use any Licensed Trademarks as of immediately prior to the Effective Date. 
 1.8 “Licensed
Trademarks” means the Trademarks set forth in Schedule 1 (Licensed Trademarks). 
 1.9
“Licensee” means each of SpinCo and the other members of the SpinCo Group. 
 1.10 “Licensed Domain
Names” means the Domain Names set forth in Schedule 2 (Licensed Domain Names). 
 1.11
“Marketing Materials” means product literature, promotional and advertising materials, sales literature, training and educational materials, store displays, splash screens and other similar materials in any forms or media. 

1.12 “Party” and “Parties” have the meaning set forth in the preamble. 

1.13 “Product Approvals” has the meaning set forth in Section 9.1. 

1.14 “Product Approval Term” has the meaning set forth in Section 9.1. 

1.15 “Separation and Distribution Agreement” or “SDA” have the meaning set forth in the
preamble. 
 1.16 “Sublicensee” has the meaning set forth in Section 2.4. 

1.17 “Term” has the meaning set forth in Section 9.1. 

1.18 “Trademark Guidelines” has the meaning set forth in Section 5.2(a). 

1.19 “Tradename Approvals” has the meaning set forth in Section 9.1. 

1.20 “Tradename Licensee” means those Licensees who have a Licensed Trademark in their Corporate Name. 

  
 2 

 2. License Grant. 

2.1 Trademark License Grant. Subject to the terms and conditions of this Agreement, Parent hereby grants to each
Licensee a fully paid-up, royalty free, non-sublicensable (except as provided in Section 2.4),
non-assignable and non-transferable, non-exclusive, worldwide transitional license to use the Licensed Trademarks in accordance
with the Trademark Guidelines and in all material respects in the same form and manner as used immediately prior to the Effective Date: 

(a) Products and Marketing Materials: in connection with the Commercialization of Licensed Products and associated
Marketing Materials within the Field for the period of time that lasts, on Licensed Product-by-Licensed Product basis and (to the extent applicable) on a country-by-country basis, until the receipt by Licensee of all licenses, permits, consents, authorizations and regulatory approvals from the applicable Governmental Authority
that are required by Law to change the Trademarks used on any Licensed Products or Marketing Materials therefor from Licensed Trademarks to Trademarks that do not include, and are not similar to, any of the Licensed Trademarks, in each case,
consistent with the timelines specified in regulations or guidance from such Governmental Authority on implementation of such changes (on Licensed Product-by-Licensed
Product basis and (to the extent applicable) on a country-by-country basis, the “Product Approvals”); provided, however, that (i) each
Licensee uses reasonable best efforts after the Effective Date to make and notify Parent of all filings with any Governmental Authority and take such other actions necessary to obtain the Product Approvals; (ii) except as set forth in subpart
(iii) below, under no circumstance shall the foregoing license expire later than two (2) years following the Effective Date (the “Product Approval Term”); (iii) in the event that a Licensee has not received all necessary
Product Approvals for a Licensed Product in a country within the Product Approval Term, and provided that such Licensee has consistently taken and continues to take at all times reasonable best efforts to obtain such Product Approval, then such
Licensee may, no later than sixty (60) days prior to the end of the Product Approval Term, solely with respect to the Licensed Product(s) in the countr(ies) for which Product Approval was not obtained within the Product Approval Term, elect in
writing to Parent to extend the Product Approval Term for such Licensed Product(s) in such countr(ies) for consecutive one (1) year terms until the necessary relevant Product Approval(s) is received; provided that, notwithstanding anything to
the contrary in this Section 2.1(a), such Licensee shall consistently continue to take at all times reasonable best efforts to expeditiously obtain such Product Approval(s); and 

(b) Other Uses: for a period of one (1) year following the Effective Date, in connection with continuing the use of
any other tangible assets, documents, or materials, not addressed in the foregoing clause (a), that contain, bear, display or use any Licensed Trademark as of the date hereof, including billboards, vehicle and equipment markings, stationery, forms,
business cards, contracts or on letterhead and other media; provided, further, that, in each case of the foregoing clauses (a)-(b) of this Section 2.1, all such uses shall be in a manner consistent with the
operation of the SpinCo Business immediately prior to the Distribution Date. For purposes of clarity, if an item requires regulatory approvals or similar approval from a Governmental Authority in a particular country to be changed, it will be
treated as Marketing Materials under the foregoing clause (a). The one (1) year term of this clause (b) may be extended for an additional one (1) year term provided that Licensee has taken at all times reasonable best efforts to
remove any Licensed Trademarks during the initial one (1) year term. 

  
 3 

 2.2 Corporate Name License Grant. 

(a) Subject to the terms and conditions of this Agreement (including Section 5.4), Parent hereby
grants to each Tradename Licensee a fully paid-up, royalty free, non-sublicensable, non-assignable and non-transferable, non-exclusive, worldwide license to use the Licensed Trademarks in its Corporate Name, until the receipt by the Tradename Licensee of all licenses, permits,
consents, authorizations and regulatory approvals from the applicable Governmental Authority that are required by Law to change the Corporate Names of all Tradename Licensees to names that do not include, and are not similar to, any of the Licensed
Trademarks (“Tradename Approvals”), provided, however, (i) each Tradename Licensee uses reasonable best efforts after the Effective Date to make and notify Parent of all filings with any Governmental Authority and
take such other actions necessary to obtain the Trademark Approvals; (ii) except as set forth in subpart (iii) below, under no circumstance shall the foregoing license expire later than two (2) years following the Effective Date (the
“Corporate Name Term”); (iii) in the event that a Tradename Licensee has not received all necessary Tradename Approvals within the Corporate Name Term, and provided that such Tradename Licensee has consistently taken and
continues to take at all times reasonable best efforts to obtain such Tradename Approvals, then such Tradename Licensee may, no later than sixty (60) days prior to the end of the Corporate Name Term, elect in writing to Parent to extend the
Corporate Name Term, with respect to such Corporate Name for which approval was not obtained, for consecutive one (1) year terms until the necessary relevant Tradename Approval is received; provided that, notwithstanding anything to the
contrary in this Section 2.2(a), such Tradename Licensee shall consistently continue to take at all times reasonable best efforts to expeditiously obtain such Tradename Approval. Upon expiration or termination of the
license granted under this Section 2.2, each Tradename Licensee shall adopt a new Corporate Name that is not confusingly similar to the Licensed Trademarks. . 

2.3 Domain Name License Grant; Domain Name Redirection. Subject to the terms and conditions of this Agreement, Parent
hereby grants to each Licensee a fully paid-up, royalty free, non-sublicensable, non-assignable and non-transferable, non-exclusive, worldwide licenses to use the Licensed Domain Name(s) for a period of thirty (30) calendar days following the Effective Date solely in
connection with the Commercialization of Licensed Products and associated Marketing Materials within the Field in all material respects in the same form and manner as used immediately prior to the Effective Date. For a period of two (2) years
following the Effective Date, in relation to any Licensed Domain Names used solely in connection with the Commercialization of Licensed Products, the Parent shall promptly reprogram each such Licensed Domain Name such that a person directed from a
third party’s hyperlink to any relevant Licensed Domain Name is immediately, and without any user intervention or action, redirected to a relevant web page address provided by the relevant Licensee of such Licensed Domain Name. 

2.4 Sublicense Rights. The licenses granted to SpinCo in Sections 2.1 shall not include any right to grant any
sublicenses except as provided in this Section 2.4. Subject to the terms and conditions of this Agreement, each Licensee may grant sublicenses to customers of the SpinCo Group (each a “Sublicensee”) in
connection with Commercialization of the Licensed Products in the Field, in the ordinary course of business, in each case solely for the benefit of the SpinCo Business; provided, that such Licensee ensures that the terms of any such
sublicense are consistent with the terms of this Agreement and any such Sublicensee complies with such sublicense. Each Licensee shall remain responsible and liable for each Sublicensee’s compliance with all of the terms and conditions of this
Agreement, and any breach of the terms or conditions of this Agreement by any Sublicensee shall be deemed a breach by such Licensee of such terms and conditions. 

  
 4 

 2.5 Efforts to Remove. 

(a) Each Licensee shall use reasonable best efforts to remove and cease using any Licensed Trademarks that appear on any
publicly available or promotional materials used by any member of the SpinCo Group or their Affiliates within the SpinCo Business as soon as reasonably practical following the Effective Date. 

(b) Notwithstanding any other provision of this Agreement to the contrary, (i) Licensee may continue to sell any inventory
of Licensed Products that are manufactured and marked with the Licensed Trademarks prior to such Licensee’s receipt of the relevant Product Approval (including, for clarity, any
works-in-process or products for which manufacturing and/or marking with the Licensed Trademarks commenced prior to such Licensee’s receipt of the relevant Product
Approval) (such Licensed Products, the “Existing Inventory”); and (ii) no Licensee shall be required to arrange the recall, relabel, repackage, destroy, or otherwise modify any Existing Inventory of any Licensed Products sold
prior to such Licensee’s receipt of the relevant Product Approval, 
 2.6 Records. Notwithstanding anything in
this Agreement to the contrary, and without limiting the rights otherwise granted in this Section 2, each Licensee shall have the right, at all times before, during and after the Effective Date, to retain internal records
and other historical or archived documents for internal use or reference that contain or bear the Licensed Trademarks. 
 2.7
Group Members. SpinCo shall cause the other Licensees to comply with all applicable provisions of this Agreement. 

2.8 Rebranding Progress Reporting. Within forty-five (45) calendar days following the end of each calendar quarter,
commencing with the first full calendar month following the Effective Date, each Licensee shall deliver to the Parent a progress report of such Licensee’s total rebranding efforts, including each of the Licensee’s obligations pursuant to
this Section 2. 
 2.9 Best Efforts. In assessing whether Licensee is taking or has taken
“reasonable best efforts” under this Section 2, the Parties acknowledge that Licensee operates in a large number of countries and in a highly complex regulatory environment, including for example the European
Union Medical Device Regulation (EUMDR). Making changes to labeling, changing the names of legal manufacturer and other similar changes must be managed in a coordinated way in order to minimize the risk of violating regulatory requirements which
could lead to the interruption of the availability of critical medical products to Licensee’s patients. As a result, the Parties acknowledge that the pace of changes related to particular countries must take into account these regulatory
complexities. The Parties also acknowledge that, pursuant to Section 10.15, acts of god, unforeseen circumstances, pandemics and the like must also be taken into consideration when assessing whether Licensee is taking or
has taken “reasonable best efforts.” 
 3. Restrictions. Except as expressly permitted in this Agreement, no Licensee
shall: 
 (a) use any of the Licensed Trademarks in a way that would reasonably be expected to (i) tarnish, degrade,
disparage or reflect adversely on a Licensed Trademark or Parent’s or any member of the Parent Group’s business or reputation, (ii) dilute or otherwise harm the value, reputation or distinctiveness of or Parent’s goodwill used in
connection with or symbolized by any Licensed Trademark or (iii) invalidate or cause the cancellation or abandonment of any Licensed Trademark; or 

(b) adopt, use, register or file applications to register, acquire or otherwise obtain, in any jurisdiction, any Trademark or
Domain Name that consists of, incorporates or is confusingly similar to or dilutive of, or is a variation, derivation or modification of, any Licensed Trademark. 

  
 5 

 4. Ownership. 

4.1 Ownership of Licensed Trademarks. Each Licensee acknowledges that as between the Parties, the Licensed Trademarks
are the exclusive and sole property of Parent, and each Licensee agrees that it will not contest Parent’s ownership or validity of any of the Licensed Trademarks. Nothing in this Agreement shall confer in any Licensee any right of ownership in
any Licensed Trademarks, and no Licensee shall make any representation to that effect or use any Licensed Trademarks in a manner that suggests that such rights are conferred. 

4.2 No Obligation to Prosecute or Maintain Trademarks. Neither Parent nor any member of the Parent Group shall have any
obligation to seek, perfect, maintain any protection for, defend, or enforce any of the Licensed Trademarks. Without limiting the generality of the foregoing, except as expressly set forth in this Agreement, neither Parent nor any member of the
Parent Group shall have any obligation to file any Trademark application, to prosecute any Trademark or secure any Trademark rights or to maintain any Licensed Trademark in force. 

5. Quality Control. 

5.1 SpinCo Covenants. 

(a) Quality Control. Each Licensee shall ensure that all Licensed Products are made and Commercialized according to
standards that are, and a level of quality that is either (i) substantially the same as the standards and quality of the SpinCo Business as of immediately prior to the Effective Date, or (ii) approved in advance in writing by Parent. 

(b) Samples. Each Licensee agrees, upon Parent’s reasonable request, to furnish to Parent representative samples of
Licensed Products or Marketing Materials Commercialized by SpinCo that include or bear the Licensed Trademarks. 
 5.2
Conditions Applicable to the Appearance of the Licensed Trademarks. 
 (a) Each Licensee agrees to comply with the
rules and brand guidelines applicable to the SpinCo Business as of immediately prior to the Effective Date with respect to the appearance and manner of use of the Licensed Trademarks (“Trademark Guidelines”) as attached in
Schedule 3 (Trademark Guidelines). Parent agrees to notify SpinCo in writing of any changes to the Trademark Guidelines. Each Licensee’s obligation to comply with revised Trademark Guidelines shall be prospective from the date of
notification of any such changes thereto, and no Licensee shall be required to modify any materials complying with the prior guidelines that were Commercialized prior to such notification. No changes to any form of use of the Licensed Trademarks
shall be adopted by any Licensee without prior approval in writing by Parent. 
 5.3 Protection of Licensed
Trademarks. 
 (a) Each Licensee shall take reasonable steps to avoid endangering the validity of the Licensed
Trademarks, including compliance with the applicable Laws in all countries where Licensed Products are Commercialized. Each Licensee shall execute registered user agreements and similar documents required by Parent to protect or enhance
Parent’s title and rights in the Licensed Trademarks. Except as otherwise provided in this Agreement, each Licensee shall be responsible for all out-of-pocket costs
and expenses incurred in connection with obtaining and maintaining trademark registrations where such registrations would not have been applied for or maintained in the absence of its activities under this Agreement, recording this Agreement and
obtaining the entry of such Licensee as a registered or authorized user of the Licensed Trademarks. 

  
 6 

 (b) In the event that any Licensee learns of any infringement or threatened
infringement of the Licensed Trademarks or any passing-off or that any third party alleges or claims to such Licensee that the Licensed Trademarks are liable to cause deception or confusion to the public, or
are liable to dilute or infringe any right, Each Licensee shall as promptly as reasonably practicable notify Parent or its authorized representative giving particulars thereof. Parent may elect to pursue such claims and any such proceedings shall be
at the sole expense of Parent and any recoveries shall be solely for the benefit of Parent. Nothing herein, however, shall be deemed to require Parent to enforce the Licensed Trademarks against others. 

(c) In the performance of this Agreement, each Licensee shall comply with all applicable Laws regarding Intellectual Property
Rights, and those Laws particularly pertaining to the proper use and designation of Trademarks. Should any Licensee become aware of any applicable Laws regarding Intellectual Property Rights that are inconsistent with the provisions of this
Agreement, it shall as promptly as reasonably practicable notify Parent of such inconsistency. 
 5.4 Protection of
Licensed Trademarks. Each Licensee shall (a) comply in all material respects at all times with applicable Laws and (b) operate its business and sell Licensed Products in accordance in all material respects with at least the same
standards of quality, appearance, service and other standards that it has observed as of the Effective Date. In order to promote adherence to such standards and for the purpose of protecting and maintaining the goodwill associated with the Licensed
Trademarks and the reputation of Parent, Parent shall have the right to obtain from each Licensee reasonable information as to the operation of such Licensee’s business regarding the Licensed Products and the manner in which the Licensed
Trademarks are used. 
 5.5 If, at any time, any Licensee fails, in the good faith reasonable opinion of Parent, to conform
or comply in all material respects to the standards and other requirements set forth in this Agreement, and Parent notifies such Licensee in writing of such failure, the Licensee promptly shall take such steps as are reasonably necessary to
conform or comply in all material respects with such standards and other requirements of this Agreement. If such Licensee fails to cure any such material non-conformity or
non-compliance within ninety (90) calendar days of such notice of nonconformity, but has taken reasonable best efforts in attempting to cure such material
non-conformity or non-compliance, then such Licensee shall have a reasonable period to cure such material non-conformity or non-compliance; provided, that such Licensee consults with Parent to determine the steps that are reasonably necessary. If such Licensee fails to cure any such material
non-conformity or non-compliance within ninety (90) calendar days of such notice of such material nonconformity or
non-compliance, and has not taken reasonable best efforts in attempting to cure such material non-conformity or non-compliance,
such Licensee shall promptly cease use of the Licensed Trademarks and Parent shall have the right to terminate this Agreement immediately upon written notice to such Licensee. 

6. Representations and Warranties; Covenants. 

6.1 Representations and Warranties. Each of Parent (on behalf of itself and its Affiliates (as applicable)) and SpinCo
(on behalf of itself and its Affiliates (as applicable)) makes the representations and warranties set forth in this Section 6.1 to the other Party as of the Effective Date. 

(a) It is duly organized, validly existing, and in good standing under the laws of its jurisdiction of formation. It has full
corporate power and authority to execute, deliver, and perform this Agreement, and the execution, delivery and performance by it of this Agreement have been duly authorized by all requisite corporate action. 

  
 7 

 (b) This Agreement constitutes a valid and legally binding agreement
enforceable against it in accordance with its terms (except as the enforceability thereof may be limited by applicable Laws). 

6.2 Compliance with Laws. Each Party shall comply, and shall cause its Affiliates and sublicenses to comply, with all
applicable Laws in performing its and their obligations and exercising its and their rights pursuant to this Agreement. 

6.3 DISCLAIMER. EXCEPT AS MAY BE EXPRESSLY PROVIDED IN SECTION 5.4 OF THIS AGREEMENT, NEITHER PARTY MAKES, AND
EACH PARTY EXPRESSLY DISCLAIMS, UNDER THIS AGREEMENT, ANY REPRESENTATIONS AND WARRANTIES, WHETHER EXPRESS OR IMPLIED AND WHETHER UNDER THIS AGREEMENT OR AT LAW, INCLUDING ANY REPRESENTATION OR WARRANTY (A) OF QUALITY, MERCHANTABILITY,
SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE, TITLE, REGISTERABILITY, ALLOWABILITY, VALIDITY OR ENFORCEABILITY, (B) ARISING FROM COURSE OF DEALING, COURSE OF PERFORMANCE OR TRADE USAGE OR (C) THAT ANY LICENSED TRADEMARK TO THE OTHER
PARTY HEREUNDER MAY BE PRACTICED WITHOUT INFRINGING THE INTELLECTUAL PROPERTY RIGHTS OF ANY THIRD PARTY. EXCEPT AS MAY EXPRESSLY BE SET FORTH HEREIN, THE LICENSED TRADEMARKS ARE BEING LICENSED ON AN “AS IS,” “WHERE IS” BASIS AND
THE RESPECTIVE TRANSFEREES SHALL BEAR THE ECONOMIC AND LEGAL RISKS RELATED TO THE USE OF THE LICENSED TRADEMARKS IN CONNECTION WITH THE SPINCO BUSINESS. 

7. Limitation of Liability. EXCEPT TO THE EXTENT ARISING FROM CLAIMS THAT A LICENSEE HAS USED ANY LICENSED TRADEMARKS OUTSIDE OF THE
SCOPE OF THE LICENSES GRANTED UNDER THIS AGREEMENT OR BREACHES BY EITHER PARTY OF SECTION 8 HEREOF, TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER PARTY WILL BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL, INDIRECT,
COLLATERAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, LOST PROFITS SUFFERED OR SIMILAR ITEMS (INCLUDING LOSS OF REVENUE, INCOME OR PROFITS, DIMINUTION OF VALUE OR LOSS OF BUSINESS REPUTATION OR OPPORTUNITY), OR DAMAGES CALCULATED ON MULTIPLES OF EARNINGS
OR OTHER METRIC APPROACHES, HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, IN CONNECTION WITH ANY DAMAGES ARISING HEREUNDER. 
 8.
Confidentiality. 
 8.1 Duty of Confidence. Subject to the other provisions of this
Section 8, all Confidential Information disclosed by a Party or its Affiliates under this Agreement will be maintained in confidence and otherwise safeguarded by the recipient Party. The recipient Party may only use and
disclose the Confidential Information of the other Party for the purposes of this Agreement. Subject to the other provisions of this Section 8, each Party shall hold as confidential such Confidential Information of the
other Party or its Affiliates in the same manner and with the same protection as such recipient Party maintains its own confidential information. Except as expressly provided in this Section 8, a recipient Party may only
disclose Confidential Information of the other Party to employees, agents, contractors, consultants and advisers of the recipient Party and its Affiliates to the extent reasonably necessary for the purposes of, and for those matters undertaken
pursuant to, this Agreement; provided that such Persons are bound to maintain the confidentiality of the Confidential Information in a manner consistent with the confidentiality provisions of this Agreement. 

  
 8 

 8.2 Exceptions. The obligations under this
Section 8 shall not apply to any information to the extent that the recipient Party can demonstrate by competent evidence that such information: 

(a) is (at the time of disclosure) or becomes (after the time of disclosure) known to the public or part of the public domain
through no breach of this Agreement by the recipient Party or its Affiliates; 
 (b) was known to, or was otherwise in the
possession of, the recipient Party or its Affiliates prior to the time of disclosure by the disclosing Party or any of its Affiliates; 

(c) is disclosed to the recipient Party or an Affiliate on a non-confidential basis by
a Third Party who is entitled to disclose it without breaching any confidentiality obligation to the disclosing Party or any of its Affiliates; or 

(d) is independently developed by or on behalf of the recipient Party or its Affiliates, as evidenced by its written records,
without reference to the Confidential Information disclosed by the disclosing Party or its Affiliates under this Agreement. 
 Specific aspects or details
of Confidential Information shall not be deemed to be within the public domain or in the possession of the recipient Party merely because the Confidential Information is embraced by more general information in the public domain or in the possession
of the recipient Party. Further, any combination of Confidential Information shall not be considered in the public domain or in the possession of the recipient Party merely because individual elements of such Confidential Information are in the
public domain or in the possession of the recipient Party unless the combination and its principles are in the public domain or in the possession of the recipient Party. 

8.3 Authorized Disclosures. In the event that the recipient Party is required to disclose Confidential
Information of the disclosing Party pursuant to applicable Law or in connection with bona fide legal process, such disclosure shall not be a breach of this Agreement; provided that the recipient Party (a) informs the disclosing Party as
soon as reasonably practicable of the required disclosure, (b) limits the disclosure to the required purpose, and (c) at the disclosing Party’s request and expense, to the extent permitted by applicable Law, assists in an attempt to
object to or limit the required disclosure. 
 9. Term and Termination; Remedies. 

9.1 Term. The term of this Agreement shall commence as of the Effective Date and unless earlier terminated in accordance
herewith (including pursuant to Section 5.5 for material uncured breach), shall continue in force until the last day of the last to expire license terms set forth in Section 2.1,
Section 2.2, or Section 2.3 (such period, the “Term”). 

9.2 Effect of Termination; Survival. Upon the expiration or termination of this Agreement, SpinCo shall immediately
discontinue and cease all use of the Licensed Trademarks and Domain Names. After the expiration or termination of the Term, SpinCo and the SpinCo Group shall no longer have the right to use the Licensed Trademarks and Domain Names. Further, the
following provisions of this Agreement shall survive any expiration or termination (whether in part or in its entirety) of this Agreement, Section 7 (Limitation of Liability), Section 8
(Confidentiality), Section 9.2 (Effects of Termination; Survival), and Section 10 (Miscellaneous) and Section 1 (Definitions) (to the extent
necessary to give effect to the foregoing sections in this sentence). 

  
 9 

 10. Miscellaneous. 

10.1 Interpretation. Unless the context of this Agreement otherwise requires: (a) words in the singular shall be
deemed to include the plural and vice versa and words of one gender shall be deemed to include the other genders as the context requires; (b) the terms “hereof,” “herein,” and “herewith” and words of similar import
shall, unless otherwise stated, be construed to refer to this Agreement (or the Separation and Distribution Agreement) as a whole (including all of the Schedules, Exhibits and Appendices hereto and thereto) and not to any particular provision of
this Agreement (or the Separation and Distribution Agreement); (c) Article, Section, Schedule, Exhibit and Appendix references are to the Articles, Sections, Schedules, Exhibits and Appendices to this Agreement (or, as applicable, or the Separation
and Distribution Agreement), unless otherwise specified; (d) unless otherwise stated, all references to any agreement (including this Agreement and the Separation and Distribution Agreement) shall be deemed to include the exhibits, schedules
and annexes (including all Schedules, Exhibits and Appendixes) to such agreement; (e) the word “including” and words of similar import when used in this Agreement (or the Separation and Distribution Agreement) shall mean
“including, without limitation,” unless otherwise specified; (f) the word “or” shall not be exclusive; (g) unless otherwise specified in a particular case, the word “days” refers to calendar days;
(h) references to “business day” shall mean any day other than a Saturday, a Sunday or a day on which banking institutions are generally authorized or required by law to close in New York, New York; (i) references herein to this
Agreement or any other agreement contemplated herein shall be deemed to refer to this Agreement or such other agreement as of the date on which it is executed and as it may be amended, modified or supplemented thereafter, unless otherwise specified;
(j) the word “extent” in the phrase “to the extent” shall mean the degree to which a subject or other thing extends, and such phrase shall not mean simply “if”; and (k) unless expressly stated to the contrary
in this Agreement or the Separation and Distribution Agreement, all references to “the date hereof,” “the date of this Agreement,” “hereby” and “hereupon” and words of similar import shall all be references to
the Effective Day. 
 10.2 Notices. All notices, requests, claims, demands or other communications under this
Agreement shall be in writing and shall be given or made (and except as provided herein, shall be deemed to have been duly given or made upon receipt) by delivery in person, by overnight courier service, by certified mail, return receipt requested,
or by e-mail, so long as confirmation of receipt of such e-mail is requested and received, to the respective Parties at the following addresses (or at such other address
for a Party as shall be specified in a notice addressed as follows: 
 If to Parent, to: 

Zimmer Biomet Holdings, Inc. 
 345
East Main Street 
 Warsaw, Indiana 46580 

Attention: General Counsel 
 E-mail: legal.americas@zimmerbiomet.com 
 with a copy (which shall not constitute notice), to: 

White & Case LLP 
 1221
Avenue of the Americas 
 New York, New York 10020-1095 

Attention: Morton A. Pierce, Esq. 

                 Michelle B. Rutta, Esq. 

                 Robert Chung, Esq. 

  
 10 

 E-mail: morton.pierce@whitecase.com 

             michelle.rutta@whitecase.com 

             robert.chung@whitecase.com 

If to SpinCo, to: 
 ZimVie Inc.

 10225 Westmoor Dr., 

Westminster, CO 80021 
 Attention:
General Counsel 
 E-mail: heather.kidwell@zimvie.com 

with a copy (which shall not constitute notice), to: 

White & Case LLP 
 1221
Avenue of the Americas 
 New York, New York 10020-1095 

Attention: Morton A. Pierce, Esq. 

                 Michelle B. Rutta, Esq. 

                 Robert Chung, Esq. 

E-mail: morton.pierce@whitecase.com 

             michelle.rutta@whitecase.com 

             robert.chung@whitecase.com 

or to such other address or addresses as the Parties may from time to time designate in writing by like notice. 

10.3 Amendment; Waiver. No provisions of this Agreement shall be deemed waived, amended, supplemented or modified by a
Party, unless such waiver, amendment, supplement or modification is in writing and signed by the authorized representative of the Party against whom it is sought to enforce such waiver, amendment, supplement or modification. 

10.4 Assignability. The rights, benefits and obligations of each Party under (or relating to) this Agreement (including
any licenses or sublicenses granted pursuant to this Agreement) are personal to such Party. A Party may not assign (including in a bankruptcy or similar proceeding) or assume in a bankruptcy or similar proceeding this Agreement or any rights,
benefits or obligations under or relating to this Agreement, in each case whether by operation of law or otherwise, without the other Party’s prior written consent (which shall not be unreasonably withheld, conditioned, or delayed); provided
that a Party may, with notice to the other Party but without the consent of the other Party, assign or transfer its rights and obligations under this Agreement in whole or in part to one or more of its Affiliates; provided that no such assignment by
a Party to an Affiliate shall release such Party from its obligations under this Agreement. In the event of a permitted assignment, this Agreement shall be binding upon and inure to the benefit of the Parties and their respective permitted
successors and permitted assigns. Any attempted assignment that contravenes the terms of this Agreement shall be void ab initio and of no force or effect. 

  
 11 

 10.5 Entire Agreement. This Agreement contains the entire agreement
between the Parties with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral or written, with respect to such matters, except for (a) the Separation and Distribution Agreement (and the Exhibits,
Schedules and Annexes thereto), (b) the other Ancillary Agreements and any other written agreement of the Parties that expressly provides that it is not superseded by this Agreement. In the event and to the extent that there shall be a conflict
between the provisions of this Agreement and the provisions of the Separation and Distribution Agreement, this Agreement shall control with respect to the subject matter hereof, and the Separation and Distribution Agreement shall control with
respect to all other matters. 
 10.6 Parties in Interest. This Agreement will inure to the benefit of and be binding
upon the Parties and their respective successors and permitted assigns. Except as expressly set forth herein, nothing in this Agreement, express or implied, is intended to confer upon any Person other than the Parties or their successors or
permitted assigns, any rights or remedies under or by reason of this Agreement. 
 10.7 Expenses. Except as otherwise
expressly provided in this Agreement, all costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be borne by the Party incurring such costs and expenses. 

10.8 Governing Law; Jurisdiction. 

(a) This Agreement and all Actions (whether in contract or tort) that may be based upon, arise out of or relate to this
Agreement or the negotiation, execution or performance hereof shall be governed by and construed and interpreted in accordance with the Laws of the State of Delaware irrespective of the choice of laws principles of the State of Delaware, including
all matters of validity, construction, effect, enforceability, performance and remedies. 
 (b) Subject to the provisions of
Article VII of the Separation and Distribution Agreement, each of the Parties hereby irrevocably and unconditionally submits to the exclusive jurisdiction of the Court of Chancery of the State of Delaware or, if such court shall not have
jurisdiction, the United States District Court for the District of Delaware, or if such court shall not have jurisdiction, the other state courts of the State of Delaware, and any appellate court from any appeal thereof, in any Action arising out of
or relating to this Agreement or the transactions contemplated hereby, and each of the Parties hereby irrevocably and unconditionally (i) agrees not to commence any such Action except in such courts, (ii) agrees that any claim in respect
of any such Action may be heard and determined in the Court of Chancery of the State of Delaware or, to the extent permitted by Law, in such other courts, (iii) waives, to the fullest extent it may legally and effectively do so, any objection
which it may now or hereafter have to the laying of venue of any such Action in the Court of Chancery of the State of Delaware or such other courts, and (iv) waives, to the fullest extent permitted by Law, the defense of an inconvenient forum
to the maintenance of such Action in the Court of Chancery of the State of Delaware or such other. 
 10.9
Counterparts. This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same agreement, and shall become effective when one or more counterparts have been signed by each of the Parties hereto or
the parties thereto, respectively, and delivered to the other Party hereto or parties thereto, respectively. 
 10.10
Headings. The article, section and paragraph headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. 

  
 12 

 10.11 Severability. If any provision of this Agreement, or the
application of any provision to any Person or circumstance, is held invalid or unenforceable by any court of competent jurisdiction, the other provisions of this Agreement shall remain in full force and effect. The Parties further agree that if any
provision contained herein is, to any extent, held invalid or unenforceable in any respect under the Laws governing this Agreement, they shall take any actions necessary to render the remaining provisions of this Agreement valid and enforceable to
the fullest extent permitted by Law and, to the extent necessary, shall amend or otherwise modify this Agreement to replace any provision contained herein that is held invalid or unenforceable with a valid and enforceable provision giving effect to
the intent of the Parties. 
 10.12 Rules of Construction. This Agreement shall be deemed to be the joint work product
of the Parties and any rule of construction that a document shall be interpreted or construed against a drafter of such document shall not be applicable. 

10.13 Specific Performance. Subject to the provisions of Article VII of the Separation and Distribution
Agreement, in the event of any actual or threatened default in, or breach of, any of the terms, conditions and provisions of this Agreement, the Party hereto, who are, or are to be, thereby aggrieved shall have the right to specific performance and
injunctive or other equitable relief in respect of their respective rights under this Agreement, in addition to any and all other rights and remedies at law or in equity, and all such rights and remedies shall be cumulative. The Parties agree that
the remedies at law for any breach or threatened breach, including monetary damages, are inadequate compensation for any loss and that any defense in any action for specific performance that a remedy at law would be adequate is waived. Any
requirements for the securing or posting of any bond with such remedy are waived by each of the Parties. 
 10.14 Rights
in Bankruptcy. All rights and licenses granted under or pursuant to this Agreement by Parent and SpinCo, including in Section 2 and Section 3, are, and shall otherwise be deemed to be, for
purposes of Section 365(n) of the U.S. Bankruptcy Code or analogous provisions of applicable Law outside the United States, licenses of right to “intellectual property” as defined under
Section 101 of the U.S. Bankruptcy Code or analogous provisions of applicable law outside the United States. Each Party agrees that the other, as licensee of such rights under this Agreement, shall retain and may fully
exercise all of its rights and elections under the U.S. Bankruptcy Code or any other provisions of applicable Law outside the United States that provide similar protection for such intellectual property. 

10.15 Force Majeure. No Party shall be deemed in default of this Agreement for any delay or failure to fulfill any
obligation (other than a payment obligation) hereunder so long as and to the extent to which any delay or failure in the fulfillment of such obligation is prevented, frustrated, hindered or delayed as a consequence of circumstances of Force Majeure.
In the event of any such excused delay, the time for performance of such obligations (other than a payment obligation) shall be extended for a period equal to the time lost by reason of the delay. A Party claiming the benefit of this provision
shall, as soon as reasonably practicable after the occurrence of any such event, (a) provide written notice to the other Party of the nature and extent of any such Force Majeure condition; and (b) use commercially reasonable efforts to
remove any such causes and resume performance under this Agreement as soon as reasonably practicable. 
 10.16 Further
Assurances. SpinCo and Parent hereby covenant and agree, without the necessity of any further consideration, to execute, acknowledge and deliver any and all such other documents and take any such other action as may be reasonably necessary or
appropriate to implement this Agreement and carry out the intent and purposes of this Agreement. 

  
 13 

 10.17 No Agency. Nothing herein contained will be construed to place
the Parties in the relationship of partners, principal and agent, or employer and employee. Neither Party will have the power to assume, create or incur liability or any obligation of any kind, express or implied, in the name of or on behalf of the
other Party by virtue of this Agreement. 
 10.18 Affiliate Status. To the extent that a Party is required hereunder
to take certain action with respect to entities designated in this Agreement as such Party’s Subsidiaries or Affiliates, such obligation shall apply to such entities only during such period of time that such entities are Subsidiaries or
Affiliates of such Party. To the extent that this Agreement requires a Subsidiary or an Affiliate of any Party to take or omit to take any action, such agreement and obligation includes the obligation of such Party to cause such Subsidiary or
Affiliate to take or omit to take such action. 
 10.19 Dispute Resolution. Article VII of the Separation and
Distribution Agreement is hereby incorporated by reference herein (but for this purpose, only to the extent applicable to this Agreement, and not to the Separation and Distribution Agreement or any other Ancillary Agreement). Parent designates its
Vice President, Chief Patent Counsel or their respective designee and SpinCo designates its Senior Patent Counsel or their respective designee for purposes of Section 7.1(a) of the Separation and Distribution Agreement.
Each Party may replace its designee upon written notice to the other Party. 
 [Signature Page Follows] 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed by their duly
authorized representatives. 
  

			
	ZIMMER BIOMET HOLDINGS, INC.
		
	By:	 	 /s/ Chad F. Phipps

	Name:	 	Chad F. Phipps
	Title:	 	Senior Vice President, General Counsel and Secretary
	
	ZIMVIE INC.
		
	By:	 	 /s/ Vafa Jamali

	Name:	 	Vafa Jamali
	Title:	 	President and Chief Executive Officer

  
 [Signature Page to
Transitional Trademark License Agreement]ex_341947.htm

Exhibit 10.1

 

STOCK YARDS BANCORP, INC. 

 

PERFORMANCE-VESTED STOCK UNIT 

GRANT AGREEMENT

 

This is a Performance-Vested Stock Unit ("PSU") Grant Agreement (this "Agreement" or "Award") dated as of ____________, 202_ (the "Grant Date"), between Stock Yards Bancorp, Inc. (the "Company") and _____ (the "Grantee").

 

RECITALS

 

	
			A.

				
			The Company adopted the Stock Yards Bancorp, Inc. 2015 Omnibus Equity Compensation Plan (the "Plan"). The Plan is administered by the Compensation Committee of the Board of Directors (the "Committee").

			

 

	
			B.

				
			The Committee has designated the Grantee as a Participant in the Plan, and wishes to set forth in this Agreement the Grantee's right to receive up to that number of PSUs set forth herein. Each PSU represents the right to receive one share of the Company's Stock, subject to the terms and conditions set forth in this Agreement and the Plan.

			

 

AGREEMENTS

 

The Grantee and the Company agree as follows:

 

1.         Grant of PSUs. The Company grants to the Grantee ______ PSUs (the "Maximum Number") on the terms and conditions set forth below and in the Plan.

 

2.        Transfer Restriction on PSUs. Until the delivery of shares of Company Stock with respect to the PSUs in accordance with the terms of this Award, the PSUs may not be sold, transferred, pledged, exchanged, hypothecated or otherwise disposed of, other than by will or pursuant to the applicable laws of descent and distribution. Any attempted sale, transfer, pledge, exchange, hypothecation or other disposition of the PSUs not specifically permitted by the Plan or this Award shall be null and void and without effect.

 

3.        Performance Restrictions; Vesting and Payment. Except as provided in Sections 4 or 5 below, if and to the extent that the performance criteria set forth on Exhibit A attached hereto are met as of the end of the Performance Period, as determined by the Committee, the resulting Applicable Percentage of the Maximum Number of PSUs shall vest and become nonforfeitable. Any PSUs that do not vest in accordance with the foregoing provisions of this Section 3 shall terminate as of the end of the Performance Period. The Applicable Percentage shall be determined by the Committee in March following the end of the Performance Period and applied to the Maximum Number then rounded down to a whole number of shares, and the resulting number of shares of Company Stock will be issued in satisfaction of the Award before the end of that month. Any such determination by the Committee shall be final and binding.

 

4.        Separation from Service Prior to the End of the Performance Period. In the event of the Grantee's Separation from Service prior to the end of the Performance Period, the following provisions shall apply:

 

4.1         Except as expressly provided below in Sections 4.2 or 5, in the event of the Grantee's Separation for any reason prior to the end of the Performance Period, the PSUs held by the Grantee shall be automatically forfeited by the Grantee as of the date of Grantee's Separation. Neither the Grantee nor any of the Grantee's successors, heirs, assigns or personal representatives shall have any rights or interests in any PSUs that are so forfeited.

 

4.2        Notwithstanding Section 4.1, if the Grantee experiences a Separation as the result of (i) the Grantee's death, (ii) Disability, or (iii) on or after age 60 when the Grantee has at least 10 years of service (a "Qualifying Termination"), a pro rata portion of the Company Stock with respect to the PSUs shall be issued at the time set forth in Section 3 above, as set forth below:

 

 

 

 

 

4.2.1         In the event of a Qualifying Termination prior to completion of the Performance Period, the Applicable Percentage of PSUs shall be determined through the end of the Performance Period in the same manner as it would for a Participant who is still in service on that date, but that percentage shall be subject to further adjustment equal to (i) the number of PSUs subject to the Award that would have vested in accordance with Section 3 above (assuming no Separation from Service had occurred), multiplied by (ii) a service fraction, the numerator of which is the number of full months the Grantee was employed or rendering services following the Grant Date through the date of the Grantee's Separation, and the denominator of which is the number of months in the Performance Period. Any PSUs that do not vest in accordance with the foregoing provisions of this Section 4.2.1 shall terminate and be forfeited as of the end of the Performance Period.

 

4.2.2         Notwithstanding Section 4.2.1, if a 409A Change (as defined below) occurs after a Qualifying Termination and prior to completion of the Performance Period, upon the date of the 409A Change, the Grantee shall vest in a prorated number of PSUs determined as described in Section 5 below, but multiplied by a service fraction, the numerator of which is the number of full months the Grantee was rendering services following the Grant Date through the date of the Grantee's Separation, and the denominator of which is the number of months in the Performance Period that expired between the Grant Date and the 409A Change. Such number of PSUs shall be paid in cash or by delivery of shares of stock as provided in Section 5 below. Any PSUs that do not vest under this provision shall terminate and be forfeited as of the date of the Change of Control.

 

5.       Change of Control. In the event a Change of Control which also constitutes a change in ownership or effective control or a change in ownership of a substantial portion of the assets of the Company within the meaning of Section 409A of the Code (a "409A Change") occurs prior to both completion of the Performance Period and a Separation from Service (other than a Qualifying Termination, which shall be governed by Section 4.2.2 above), a number of PSUs shall become fully vested on the date of such 409A Change as if all performance were at the Target performance level set out on Exhibit A for the Performance Period. Absent a decision by the Committee consistent with Section 16.2 of the Plan to have the securities of the surviving entity resulting from the Change of Control substituted for the number of shares of Company Stock that would otherwise have been issued based on such vesting, each vested PSU shall be converted to cash based on the Fair Market Value received by shareholders of record for Company Stock in the Change of Control. Within 5 days after the 409A Change, such cash amount or the surviving company's stock (as the case may be) shall be paid or delivered to the Grantee. Any PSUs that do not vest under this provision shall terminate and be forfeited as of the date of the Change of Control.

 

6.         Tax Withholding. The Company (or Stock Yards Bank & Trust, as the employer) shall withhold from wages otherwise due, or retain from any payment to the Grantee in respect of the PSUs, or take such other action which Company deems necessary to satisfy any income or other tax withholding requirements as a result of the vesting of PSUs and issuance of Company Stock related thereto. Unless an affirmative election is made by the Participant before the end of the Performance Period (or Change of Control, if earlier) to (i) remit already-owned shares of Company Stock, (ii) remit a cash payment, (iii) to have amounts debited from other wages due, or (iv) some combination thereof, the Grantee shall be deemed to have elected to satisfy any federal and state tax withholding requirements through a reduction in the number of shares of Company Stock issuable upon vesting, equal to their Fair Market Value based on the amount of withholding taxes reasonably estimated by the Company to be due upon vesting.

 

7.         Delay in Payment to Specified Employees. Notwithstanding anything herein to the contrary, the date of delivery of Company Stock (or cash in lieu thereof if required hereby) to the Grantee shall be delayed if payment would otherwise be required hereunder after Separation from Service (other than on account of Death) and before 6 months have elapsed from the date of the Separation from Service, if the Grantee is a Specified Employee and the circumstances of payment require delay under 409A of the Code. "Specified Employee" shall have the meaning given in Treas. Reg. § 1.409A-1(i) (or any successor thereto) using the prior calendar year as the determination period.

 

2

 

 

8.         Definitions.

 

8.1         "Separation from Service" or simply "Separation" as used herein shall mean the date the Company and the Grantee reasonably anticipate that the Grantee will not perform any further services for the Company or any other entity considered a single employer with the Company under Section 414(b) or (c) of the Code (inserting in lieu of 80% each time it is used thereunder with 50%) (together referred to herein as the "Controlled Group"). A Grantee shall not be considered to have incurred a Separation if the Grantee changes to part-time status, or serves as both member of the Board of Directors and as an employee, and only one of those two service arrangements ends, such that vesting of PSUs will continue as long as one or the other service arrangement continues during a Performance Period. The Grantee will not be treated as having a Separation from Service while on military leave, sick leave or other bona fide leave of absence if the leave does not exceed six months or, if longer, the period during which the Grantee has a reemployment right with the corporation by statute or contract. If a bona fide leave of absence extends beyond six months, a Separation from Service will be deemed to occur on the first day after the end of such six-month period, or on the day after the Grantee's statutory or contractual reemployment right lapses, if later.

 

8.2         Capitalized terms used in this Agreement and not defined herein shall have the meanings given in the Plan.

 

9.        Restrictions Imposed by Law. Notwithstanding any other provision of this Agreement, the Grantee agrees that the Company will not be obligated to deliver any shares of Company Stock if counsel to the Company determines that such exercise, delivery or payment would violate any law or regulation of any governmental authority or any agreement between the Company and any national securities exchange upon which the Company Stock is listed.

 

10.       No Shareholder Status; No Dividends. The Grantee shall have no rights as a shareholder with respect to any PSUs or shares of Company Stock under this Agreement until such shares have been duly issued and delivered to the Grantee. No adjustment shall be made for dividends of any kind or description whatsoever or for distributions of other rights of any kind or description whatsoever respecting the shares prior to such issuance. Grantee shall have no Dividend Equivalent rights hereunder.

 

11.      Modification, Amendment and Cancellation. The Committee or Board of Directors of the Company shall have the right unilaterally to modify, amend or cancel this Award in accordance with the terms of the Plan. This Award shall be subject to adjustment for changes in the Company's capitalization as provided in the Plan.

 

12.       Provisions Consistent with Plan. This Agreement is intended to be construed to be consistent with, and is subject to, all applicable provisions of the Plan, including Section 8 thereof, and the Plan is incorporated herein by reference. In the event of a conflict between the provisions of this Agreement and the Plan, the provisions of the Plan shall prevail.

 

13.     Clawback. By accepting the grant made under this Agreement, the Grantee agrees that the Company may recover some or all of the Company Stock transferred to the Grantee under this Agreement, or recoup some or all of the value thereof via offset from other amounts owed to the Grantee by the Company or its affiliate bank, at any time in the three calendar years following such Company Stock's delivery to the Grantee, if and to the extent that the Company's compensation committee concludes that (i) federal or state law or the listing requirements of the exchange on which the Company's stock is listed for trading so require, (ii) the performance criteria required herein were not met, or not met to the extent necessary to support delivery of the same number of shares, or (iii) as required by Section 304 of the Sarbanes-Oxley Act of 2002, after a restatement of the Company's financial results as reported to the Securities and Exchange Commission. The Grantee agrees to promptly comply with any Company demand for recovery or recoupment.

 

3

 

 

14.       Post-Vesting Holding Requirement. By accepting delivery of any Company Stock (net of such shares withheld for taxes as provided in Section 6 above) at vesting of a PSU hereunder, the Grantee accepts and agrees to the following restriction on transfer of that Company Stock, for a period of 12 months following its issuance hereunder, or, if earlier, until the date that the Grantee incurs a Separation from Service (the "Holding Period"). During the Holding Period, the Grantee may not sell, assign, gift or otherwise transfer the Company Stock delivered hereunder, other than in connection with a Change of Control. The Company may hold the Grantee's issued Company Stock in escrow during this Holding Period, or may place a legend on such certificates, as it deems necessary or appropriate to enforce this holding requirement.

 

 

	 	
			STOCK YARDS BANCORP, INC.

			 

			By:                                                                        

			Richard A. Lechleiter

			 

			Title: Chair, Compensation Committee 

			 

			Date: __________________________________

			 

			 

			 

			 

			GRANTEE:

			 

			                                                                              

			Signature

			 

			                                                                              

			Printed Name

			 

			(acknowledging receipt and conditions set out above)

			 

			Date: __________________________________

			

 

 

4

 

 

EXHIBIT A

 

PERFORMANCE-BASED VESTING

 

Subject to Sections 4 and 5 of this Grant Agreement, the PSUs shall vest and become nonforfeitable in the Applicable Percentage of the Maximum Number of PSUs. The Applicable Percentage shall range from 0-100% and shall be determined based on the Company's actual Three-Year Aggregate EPS for the Performance Period, plus the Company's Percentile ROAA Ranking for the Performance Period, with the portion of the Applicable Percentage related to each performance measure as set forth in the charts below:

 

	Percentile ROAA Ranking	Applicable Percentage
	Maximum: 90th or higher	50%
	Target: 85th – 89th	20%
	Threshold: 80th – 84th	  8%
	79th or below	  0%

          

Plus

 

	Three-Year Aggregate EPS	Applicable Percentage
	Maximum: $ 	50%
	Target: $ 	20%
	Threshold: $	  8%
	Below $	  0%

 

For example, if at the end of the Performance Period the Committee determined that the Company ranked above the 90th percentile to peers in ROAA, and had Three-Year Aggregate EPS of $____, the Applicable Percentage would be 100% and the Maximum Number of PSUs would be converted to and paid in shares of Company Stock.

 

Any PSUs that do not vest based on the performance requirements set forth in this Exhibit A (and which have not previously terminated pursuant to the terms of the Grant Agreement) will automatically terminate as of the last day of the Performance Period.

 

For purposes of the Award, the following definitions shall apply:

 

	 	
			●

				
			"EPS" means the diluted earnings per share of the Company as determined for financial reporting purposes consistent with Financial Accounting Standard 128 (now ASC 260), excluding any acquisition costs and restructuring adjustments made to EPS as a result of a business combination that occurs during the Performance Period in accordance with Financial Accounting Standard 141 (revised; now ASC 805).

			

 

	 	
			●

				
			"Three-Year Aggregate EPS" means the total of the Company's EPS in each of the years in the Performance Period.

			

 

	 	
			●

				
			"Percentile Ranking" means the percentile ranking of the simple average of the Company's Return on Average Assets (ROAA) for the years in the Performance Period, as compared to the simple average ROAA of all public banks with between $6.0 billion and $16.0 billion in total assets, as measured and published by S&P Global Market Intelligence or its successor.

			

 

	 	
			●

				
			"Performance Period" means the period commencing on the January 1 immediately prior to the Grant Date and ending three years thereafter.

			

 

	 	
			●

				
			"ROAA" or Return on Average Assets" means the Company's (or peer companies') net income (in the case of the Company, determined in a manner consistent with the definition of EPS above) divided by average assets for a calendar year, with average assets determined based on assets as of the same reporting periods for the Company as is used in determining average assets in S&P Global Market Intelligence’s rankings each year.

			

 

The Committee shall make all determinations regarding the achievement of Percentile ROAA Ranking and Three-Year Aggregate EPS based on Company financial statements as filed with the Securities and Exchange Commission, and the peer group rankings based on publicly available information, and the determination of the Committee shall be final and binding on all parties.

 

If the number of shares outstanding changes during the year as a result of a stock dividend or split, the aggregate EPS targets set out above will be adjusted to the same extent and in the same fashion as Generally Accepted Accounting Principles require EPS measures be adjusted.

 

*         *         *         *         *

 

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00341-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00341-of-00352.parquet"}]]